FTI was established to develop a carbon-nano-tube (CNT) based platform technology (CNT-p) for the detection of disease proteins, health markers, and environmental molecules. This CNT-based platform may result in detection with high-sensitivity and very low cost, making it affordable for the general public and thus could reform the preventive medicinal system in the future. FTI will develop the modality of detection and diagnosis for selective protein and molecular recognition of a target analyte in collaboration with nearby university, government labs and other industries.